Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans
2 december 2015 uppdaterad av: Case Comprehensive Cancer Center
This randomized clinical trial uses an educational brochure and online tutorial program to assess sun-protective behavior and skin self-examination among African Americans.
Skin cancer is very common among African Americans, with a disproportionately high mortality rate.
Providing a brochure and an online educational program about sun-protective behaviors may encourage African Americans to take preventative measures against skin cancer, help improve early skin cancer detection, determine how far the disease has spread, and plan the best treatment.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
PRIMARY OBJECTIVES:
I. To assess whether an educational brochure and online program will increase sun-protective behaviors among African-American patients who present at the general dermatology clinic.
SECONDARY OBJECTIVES:
I. To assess whether the educational brochure and online program will improve skills for skin self-examinations among African-American patients who present at the general dermatology clinic.
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Participants receive a skin cancer educational and preventive brochure distributed by the National Cancer Institute and watch a 30-minute online tutorial video called X-Plain about skin cancer, preventative behaviors, and skin self-examinations.
ARM II: Participants receive an educational brochure as in Arm I.
After completion of study, participants are followed up at 30 days.
Studietyp
Interventionell
Inskrivning (Faktisk)
143
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Ohio
-
Cleveland, Ohio, Förenta staterna, 44106-5065
- Case Comprehensive Cancer Center
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Self-identified African-Americans who are literate and fluent in English
Exclusion Criteria:
- Non-African-Americans
- English illiteracy
- non-fluency in English
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Arm I (educational brochure, online educational tutorial)
Participants receive a skin cancer educational and preventive brochure distributed by the National Cancer Institute and watch a 30-minute online tutorial video called X-Plain about skin cancer, preventative behaviors, and skin self-examinations.
|
Receive brochure with skin cancer education and preventative information
Andra namn:
Watch 30-minute online tutorial video about skin cancer, preventive behaviors, and skin self-examinations
Andra namn:
|
|
Aktiv komparator: Arm II (educational brochure)
Participants receive an educational brochure as in Arm I.
|
Receive brochure with skin cancer education and preventative information
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in sunscreen use among African-American patients
Tidsram: Baseline to day 30
|
Change in sun-protective behaviors among African-American patients.
Measured by sunscreen use.
All responses for questions about sun-protective behaviors are on a 5-point Likert scale.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
Treatment scores individuals on the intervention group will be compared.
T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups.
|
Baseline to day 30
|
|
Change in apparel use when exposed to sun among African-American patients
Tidsram: Baseline to day 30
|
Change in sun-protective behaviors among African-American patients.
Measured by apparel use when exposed to sun.
All responses for questions about sun-protective behaviors are on a 5-point Likert scale.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
Treatment scores individuals on the intervention group will be compared.
T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups.
|
Baseline to day 30
|
|
Change in frequency of tanning among African-American patients
Tidsram: Baseline to day 30
|
Change in sun-protective behaviors among African-American patients.
Measured by frequency of tanning.
All responses for questions about sun-protective behaviors are on a 5-point Likert scale.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
Treatment scores individuals on the intervention group will be compared.
T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups.
|
Baseline to day 30
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in skin self-examinations among African-American patients as measured by knowledge, behavior and anxiety
Tidsram: Baseline to day 30
|
Analyzed by looking at increase or decrease in skin self-examinations the patients report from pre-intervention to post-intervention.
Performance of skin self-examination is measured by knowledge, behavior, and anxiety.
Most responses for questions about skin self-examinations are on a 5-point Likert scale, while some are yes/no or true/false.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
T-tests will be used to compare mean scores for skin self-examinations between groups.
|
Baseline to day 30
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Jeremy Bordeaux, Case Comprehensive Cancer Center
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 april 2015
Primärt slutförande (Faktisk)
1 september 2015
Avslutad studie (Faktisk)
1 september 2015
Studieregistreringsdatum
Först inskickad
13 april 2015
Först inskickad som uppfyllde QC-kriterierna
15 april 2015
Första postat (Uppskatta)
16 april 2015
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
3 december 2015
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
2 december 2015
Senast verifierad
1 december 2015
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- CASE1615 (Annan identifierare: Case Comprehensive Cancer Center)
- P30CA043703 (U.S.S. NIH-anslag/kontrakt)
- NCI-2015-00481 (Registeridentifierare: CTRP (Clinical Trial Reporting Program))
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .